The role of gut microbiota in cancer treatment: friend or foe?Wing Yin Cheng, Chun-Ying Wu, Jun Yu
5 August 2020
Interaction between drugs and the gut microbiomeRinse K Weersma, Alexandra Zhernakova, Jingyuan Fu
14 May 2020
COVID-19 and immunomodulation in IBDMarkus F Neurath
17 April 2020
Regulatory T-cell therapy in Crohn’s disease: challenges and advancesJennie N Clough, Omer S Omer, Scott Tasker, Graham M Lord, Peter M Irving
24 January 2020
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utilityMihnea Paul Dragomir, Scott Kopetz, Jaffer A Ajani, George Adrian Calin
7 February 2020
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cellsNick Powell, Eirini Pantazi, Polychronis Pavlidis, Anastasia Tsakmaki, Katherine Li, Feifei Yang, Aimee Parker, Carmen Pin, Domenico Cozzetto, Danielle Minns, Emilie Stolarczyk, Svetlana Saveljeva, Rami Mohamed, Paul Lavender, Behdad AfzaliSee the full list of authors
2 December 2019
Liver organoids: from basic research to therapeutic applicationsNicole Prior, Patricia Inacio, Meritxell Huch
12 July 2019
miRNAs and NAFLD: from pathophysiology to therapyMonika Gjorgjieva, Cyril Sobolewski, Dobrochna Dolicka, Marta Correia de Sousa, Michelangelo Foti
12 July 2019
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?Silvio Danese, Marjorie Argollo, Catherine Le Berre, Laurent Peyrin-Biroulet
21 June 2019
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advancesSebastian Zundler, Emily Becker, Lisa Lou Schulze, Markus F Neurath
24 May 2019